Subsequently, we investigated the functional role of IL-6 in the generation and maintenance of NSCLC LCSs, by exposing secondary NCI-H460 and PEd/10 LCSs to a blocking mAb to IL-6 (anti-IL-6). Here, IL6 is linked to non-small cell lung carcinoma.